20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Net Income 2024–2025
20/20 Biolabs, Inc. annual/quarterly net income history and growth rate from 2024 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- 20/20 Biolabs, Inc. net income for the quarter ending March 31, 2026 was -2.2 M, a 184.45% increase year-over-year.
- 20/20 Biolabs, Inc. annual net income for 2025 was -3.7 M, a 32.65% decrease from 2024.
- 20/20 Biolabs, Inc. annual net income for 2024 was -5.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
20/20 Biolabs, Inc. Net Income — FAQ
20/20 Biolabs, Inc. (AIDX) net income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is 20/20 Biolabs, Inc.'s net income?
20/20 Biolabs, Inc. (AIDX) reported net income of -$4M for fiscal 2025.
Where can I see AIDX's net income history?
The chart and table above show 20/20 Biolabs, Inc.'s net income by year and by quarter, including the growth rate.